Free Trial
NASDAQ:AVR

Anteris Technologies Global Q2 2025 TU Earnings Report

Anteris Technologies Global logo
$7.25 +0.72 (+11.03%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$7.31 +0.06 (+0.80%)
As of 04:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Anteris Technologies Global EPS Results

Actual EPS
-$0.58
Consensus EPS
-$0.53
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

Anteris Technologies Global Revenue Results

Actual Revenue
$0.62 million
Expected Revenue
$0.58 million
Beat/Miss
Beat by +$38.00 thousand
YoY Revenue Growth
N/A

Anteris Technologies Global Announcement Details

Quarter
Q2 2025 TU
Time
Before Market Opens
Conference Call Date
Monday, August 11, 2025
Conference Call Time
6:00PM ET

Earnings Documents

Anteris Technologies Global Earnings Headlines

Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel
See More Anteris Technologies Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email.

About Anteris Technologies Global

Anteris Technologies Global (NASDAQ:AVR) engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

View Anteris Technologies Global Profile